A Phase 3 Multicenter Investigator-blind Randomized Parallel Group Study to Investigate the Safety and Efficacy of Fidaxomicin Oral Suspension or Tablets Taken q12h and Vancomycin Oral Liquid or Capsules Taken q6h for 10 Days in Pediatric Subjects with Clostridium difficile-associated Diarrhea
-
- STATUS
- Not Recruiting
Summary
This is a multi-center, open label study designed to evaluate the safety and tolerability of Fidaxomicin oral suspension or tablets in pediatric subjects, ages 6 months to 18 years of age with Clostridium difficile-associated diarrhea (CDAD), following the administration of doses given every 12 hours for 10 consecutive days.
Description
This is a multi-center, open label study designed to evaluate the safety and tolerability of Fidaxomicin oral suspension or tablets in pediatric subjects, ages 6 months to 18 years of age with Clostridium difficile-associated diarrhea (CDAD), following the administration of doses given every 12 hours for 10 consecutive days.
Details
| Condition | Clostridium difficile-associated Diarrhea |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX4380 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.